Leaflet TRASYLOL 500000 UIK solution for infusion
Aprotinin is a protease inhibitor used to reduce blood loss during major surgical procedures, such as cardiac surgery with cardiopulmonary bypass. It works by inhibiting proteolytic enzymes such as trypsin, plasmin, and kallikrein, thereby preventing fibrin degradation and reducing the risk of excessive bleeding.
Aprotinin is administered intravenously, usually during surgery, according to a specific protocol. It is often used in patients at high risk of bleeding or requiring massive transfusions.
Side effects may include allergic reactions, renal failure, or thrombotic events. Its use requires careful monitoring, especially in patients with pre-existing conditions.
Aprotinin is a valuable medication in managing intraoperative blood loss, helping to reduce the need for transfusions and improve surgical outcomes.
Aprotinin is administered intravenously, usually during surgery, according to a specific protocol. It is often used in patients at high risk of bleeding or requiring massive transfusions.
Side effects may include allergic reactions, renal failure, or thrombotic events. Its use requires careful monitoring, especially in patients with pre-existing conditions.
Aprotinin is a valuable medication in managing intraoperative blood loss, helping to reduce the need for transfusions and improve surgical outcomes.
General data about TRASYLOL 500000 UIK
- Substance:
- aprotinin
- Date of latest medicines list:
- 01-07-2013
- Product code:
- W12746001
- Concentration:
- 500000UIK
- Pharmaceutical form:
- solution for infusion
- Quantity:
- 1
- Product type:
- Original
- Prescription status:
- S — Medicines dispensed with a restricted medical prescription, reserved for use in certain specialized fields.
Pharmaceutical forms available for aprotinin
Concentrations available for aprotinin
- 100000KUI/ml
- 10000UKI
- 500000KUI/50ml
- 500000UIK